RTX A/S logo

RTX A/S (RTE)

Market Open
14 Aug, 20:00
XMUN XMUN
12. 85
0
0%
- Market Cap
30.5 P/E Ratio
- Div Yield
0 Volume
0 Eps
12.85
Previous Close
Add Transaction
Day Range
12.85 12.85
Year Range
11.1 15.7
Want to track RTE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RTE trading today higher at €12.85, an increase of 0% from yesterday's close, completing a monthly decrease of -1.1538% or -€0.15. Over the past 12 months, RTE stock lost -10.1399%.
RTE is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XDUS (EUR).

RTE Chart

RTX A/S (RTE) FAQ

What is the stock price today?

The current price is €12.85.

On which exchange is it traded?

RTX A/S is listed on XMUN.

What is its stock symbol?

The ticker symbol is RTE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has RTX A/S ever had a stock split?

No, there has never been a stock split.

RTX A/S Profile

Biotechnology Industry
Healthcare Sector
Mr. Dao Xing Fu CEO
XMUN Exchange
- ISIN
CN Country
4,858 Employees
- Last Dividend
- Last Split
18 May 1998 IPO Date

Overview

Beijing Tiantan Biological Products Co., Ltd. is a prominent player in the biopharmaceutical industry, primarily focused on the research and development, manufacture, sale, and consulting of blood products. Founded in 1919 and with its headquarters established in Beijing, China, this company has carved a niche for itself in the Chinese biopharmaceutical sector. As a subsidiary of China National Biotec Group Company Limited, Beijing Tiantan Biological Products operates under a considerable banner, contributing significant advancements and innovations in the field of biotechnology and pharmaceuticals, with a strong emphasis on products derived from human blood.

Products and Services

The company's portfolio encompasses a diverse range of blood-related products, tailored to meet a variety of medical needs. Their product lineup includes:

  • Human Albumin: A vital protein used in the treatment of shocks, burns, and low blood protein levels. It plays a crucial role in maintaining blood volume and pressure.
  • Intravenous Human Immunoglobulin: A therapy used for a range of immune deficiencies and autoimmune and inflammatory diseases, providing essential antibodies to patients with deficient or malfunctioning immune systems.
  • Tetanus Human Immunoglobulin: Specifically used for the prevention and treatment of tetanus, offering immediate immunity through the provision of tetanus antibodies.
  • Rabies Patient Immunoglobulin: Used as post-exposure prophylaxis against rabies infections, providing immediate but temporary antibodies to fight the virus following exposure.
  • Hepatitis B Human Immunoglobulin: Administered to prevent hepatitis B infection in individuals exposed to the virus, as well as in other specific medical situations like the newborns of mothers who are hepatitis B surface antigen positive.
  • Freeze-dried Intravenous Hepatitis B Human Immunoglobulin: A specialized formulation of hepatitis B immunoglobulin, designed for intravenous administration, offering convenience and improved stability.
  • Human Prothrombin Complex: This product is crucial for patients with clotting disorders, providing a concentrate of clotting factors to manage and prevent bleeding episodes.

Contact Information

Address: No.B2 Shuangqiao Road, Beijing, China, 100024
Phone: 86 10 6543 4018